2010•PubMedRequires access
Survival at 1, 3, and 5 years in diabetic and nondiabetic patients on hemodialysis.
Seyed Seifollah Beladi Mousavi, Fatemeh Hayati, Mohammad Javad Alemzadeh‐Ansari, Ehsan Valavi, Bahman Cheraghian, Heshmatollah Shahbazian, Khadijeh Golzari, Ali Reza Ghorbani, Homira Rashidi, Peyman Payami, Bahman Ghaderian, Esmaeel Eideni
Open publisher page 32 citations
Abstract
We analyzed survival of 185 adult patients on maintenance hemodialysis (9 h/wk to 12 h/wk) at Emam Khomini Hospital in Ahvaz, Iran. Patient survival at 1, 3, and 5 years was 89.2%, 69.2%, and 46.8%, respectively. There was no significant difference between diabetic and nondiabetic patients in 1-year survival (87.1% versus 89.7%, P = .66). But, 3- and 5-year survival rates of diabetic patients were significantly lower than those of nondiabetic patients (52.2% versus 73.8%, P = .04; zero versus 56.9%, P < .001; respectively). Based on our findings, the survival of diabetic patients undergoing hemodialysis was much worse than survival of nondiabetic patients. Thus, prevention of diabetic nephropathy should be more emphasized; and if end-stage renal disease is present, other renal replacement therapies such as kidney transplantation must be considered as soon as possible.